Status: Active
Hilo SA
- Status Current
- Sectors Hypertension, Patient Monitoring
- Year Invested 2021
- HQ Neuchâtel, Switzerland
- Clinical Operations Germany, Switzerland, France, UK
- Lead Partner Frederik Groenewegen
Website www.hilo.com
Related News
- Aktiia secures $42 million in Series B funding round and rebrands to Hilo
- Swiss Health Tech Startup, Aktiia, Names Industry Veteran, Rags Gupta, New CEO, As Part of Global Push to Transform Blood Pressure Monitoring and Management
- Aktiia receives CE Mark for CALFREE optical blood pressure technology
- Aktiia Secures CHF 27 Million (USD 30M) in Funding from Khosla Ventures and Others, Welcomes Daniel Graf as New President and Board Member to Accelerate Innovation in Hypertension Management
- Aktiia Closes $17.5 Million Series A Financing Round
Automatic, Continues Optical Blood Pressure Monitoring
Commercial-stage company pioneering new ways to track, analyze and optimize blood pressure control, enabling physicians to deliver more targeted and timely care.